PVCT
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Capitalization
32.78M
RVPH
Price
$0.80
Change
-$0.01 (-1.23%)
Updated
Jun 5 closing price
Capitalization
37.29M
73 days until earnings call
Interact to see
Advertisement

PVCT vs RVPH

Header iconPVCT vs RVPH Comparison
Open Charts PVCT vs RVPHBanner chart's image
Provectus Biopharmaceuticals
Price$0.08
Change-$0.00 (-0.00%)
Volume$156.39K
Capitalization32.78M
Reviva Pharmaceuticals Holdings
Price$0.80
Change-$0.01 (-1.23%)
Volume$511.38K
Capitalization37.29M
PVCT vs RVPH Comparison Chart
Loading...
PVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PVCT vs. RVPH commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PVCT is a Hold and RVPH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (PVCT: $0.08 vs. RVPH: $0.80)
Brand notoriety: PVCT and RVPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PVCT: 95% vs. RVPH: 69%
Market capitalization -- PVCT: $32.78M vs. RVPH: $37.29M
PVCT [@Biotechnology] is valued at $32.78M. RVPH’s [@Biotechnology] market capitalization is $37.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PVCT’s FA Score shows that 1 FA rating(s) are green whileRVPH’s FA Score has 1 green FA rating(s).

  • PVCT’s FA Score: 1 green, 4 red.
  • RVPH’s FA Score: 1 green, 4 red.
According to our system of comparison, both PVCT and RVPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PVCT’s TA Score shows that 4 TA indicator(s) are bullish while RVPH’s TA Score has 4 bullish TA indicator(s).

  • PVCT’s TA Score: 4 bullish, 3 bearish.
  • RVPH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PVCT is a better buy in the short-term than RVPH.

Price Growth

PVCT (@Biotechnology) experienced а -11.48% price change this week, while RVPH (@Biotechnology) price change was -10.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

PVCT is expected to report earnings on Mar 28, 2025.

RVPH is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVPH($37.3M) has a higher market cap than PVCT($32.8M). PVCT YTD gains are higher at: -35.054 vs. RVPH (-55.923). PVCT has higher annual earnings (EBITDA): -2.78M vs. RVPH (-33.27M). RVPH has more cash in the bank: 5.56M vs. PVCT (187K). RVPH has less debt than PVCT: RVPH (83K) vs PVCT (2.8M). PVCT (0) and RVPH (0) have equivalent revenues.
PVCTRVPHPVCT / RVPH
Capitalization32.8M37.3M88%
EBITDA-2.78M-33.27M8%
Gain YTD-35.054-55.92363%
P/E RatioN/AN/A-
Revenue00-
Total Cash187K5.56M3%
Total Debt2.8M83K3,375%
FUNDAMENTALS RATINGS
PVCT vs RVPH: Fundamental Ratings
PVCT
RVPH
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9189
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PVCT's Valuation (4) in the null industry is significantly better than the same rating for RVPH (93). This means that PVCT’s stock grew significantly faster than RVPH’s over the last 12 months.

PVCT's Profit vs Risk Rating (78) in the null industry is in the same range as RVPH (100). This means that PVCT’s stock grew similarly to RVPH’s over the last 12 months.

PVCT's SMR Rating (100) in the null industry is in the same range as RVPH (100). This means that PVCT’s stock grew similarly to RVPH’s over the last 12 months.

RVPH's Price Growth Rating (89) in the null industry is in the same range as PVCT (91). This means that RVPH’s stock grew similarly to PVCT’s over the last 12 months.

RVPH's P/E Growth Rating (11) in the null industry is significantly better than the same rating for PVCT (100). This means that RVPH’s stock grew significantly faster than PVCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PVCTRVPH
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
PVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LMAT83.561.01
+1.22%
LeMaitre Vascular
NTES128.621.40
+1.10%
NetEase
XPL0.68N/A
+0.30%
Solitario Resources Corp
FLS47.18-0.23
-0.49%
Flowserve Corp
AIRS4.59-0.03
-0.65%
AirSculpt Technologies

PVCT and

Correlation & Price change

A.I.dvisor tells us that PVCT and LABFF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PVCT and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVCT
1D Price
Change %
PVCT100%
+0.39%
LABFF - PVCT
23%
Poorly correlated
N/A
RVPH - PVCT
20%
Poorly correlated
-2.05%
PPTDF - PVCT
17%
Poorly correlated
N/A
PTIX - PVCT
12%
Poorly correlated
-8.29%
PRRUF - PVCT
11%
Poorly correlated
N/A
More

RVPH and

Correlation & Price change

A.I.dvisor tells us that RVPH and GYRE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVPH and GYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
-2.05%
GYRE - RVPH
30%
Poorly correlated
-7.46%
CDIO - RVPH
28%
Poorly correlated
-10.62%
TSHA - RVPH
27%
Poorly correlated
+3.05%
ALT - RVPH
25%
Poorly correlated
-0.55%
INM - RVPH
25%
Poorly correlated
-3.61%
More